Macrophages and the hypoxic tumour microenvironment

Frontiers in Bioscience

Volumn 12, Issue 11, 2007, Pages 4298-4314

  Knowles, Helen J ^a   Harris, Adrian L ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Angiogenesis; Hypoxia; Immunosuppression; Metastasis; Migration; Review; TAM; Therapy; Tumour associated macrophage

Indexed keywords

ANTINEOPLASTIC AGENT;

CELL HYPOXIA; CYTOLOGY; HUMAN; MACROPHAGE; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROGNOSIS; REVIEW; VASCULARIZATION;

ANTINEOPLASTIC AGENTS; CELL HYPOXIA; HUMANS; MACROPHAGES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS;

EID: 34347231274     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2389     Document Type: Article

References (170)

1. Kelly P. M., R. S. Davison, E. Bliss & J. O. McGee: Macrophages in human breast disease: a quantitative immunohistochemical study. Br J Cancer 57, 174-177 (1988) (Pubitemid 18085399)
2. Leek R. D., A. L. Harris & C. E. Lewis: Cytokine networks in solid human tumors: regulation of angiogenesis. J Leukoc Biol 56, 423-435 (1994) (Pubitemid 24319901)
3. Wilbanks G. D., M. C. Ahn, D. A. Beck & D. P. Braun: Tumor cytotoxicity of peritoneal macrophages and peripheral blood monocytes from patients with ovarian, endometrial, and cervical cancer. Int J Gynecol Cancer 9, 427-432 (1999)
4. Bingle L., N. J. Brown & C. E. Lewis: The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 196, 254-265 (2002) (Pubitemid 34189413)
5. Sica A., T. Schioppa, A. Mantovani & P. Allavena: Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42, 717-727 (2006)
6. Steele R. J., O. Eremin, M. Brown & R. A. Hawkins: A high macrophage content in human breast cancer is not associated with favourable prognostic factors. Br J Surg 71, 456-458 (1984) (Pubitemid 14116573)
7. Tsutsui S., K. Yasuda, K. Suzuki, K. Tahara, H. Higashi & S. Era: Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep 14, 425-431 (2005)
8. Leek R. D., C. E. Lewis, R. Whitehouse, M. Greenall, J. Clarke & A. L. Harris: Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56, 4625-4629 (1996) (Pubitemid 26338061)
9. Visscher D. W., P. Tabaczka, D. Long & J. D. Crissman: Clinicopathologic analysis of macrophage infiltrates in breast carcinoma. Pathol Res Pract 191, 1133-139 (1995) (Pubitemid 26031759)
10. An T., U. Sood, T. Pietruk, G. Cummings, K. Hashimoto & J. D. Crissman: In situ quantitation of inflammatory mononuclear cells in ductal infiltrating carcinoma. Relation to prognostic parameters. Am J Pathol 128, 52-60 (1987) (Pubitemid 17094335)
11. Hanada T., M. Nakagawa, A. Emoto, T. Nomura, N. Nasu & Y. Nomura: Prognostic value of tumour-associated macrophage count in human bladder cancer. Int J Urol 7, 263-269 (2000) (Pubitemid 30440592)
12. Flamm J. & A. Benesch: Tumor-associated mononuclear cell infiltrate and recurrence rate in the superficial urothelial carcinoma of the urinary bladder. Urol Int 41, 187-191 (1986) (Pubitemid 16040877)
13. Koide N., A. Nishio, T. Sato, A. Sugiyama & S. Miyagawa: Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus. Am J Gastroenterol 99, 1667-1674 (2004) (Pubitemid 39237489)
14. Ma Y., M. Xian, J. Li, T. Kawabata & S. Okada: Interrelations of clinicopathological variables, local immune response and prognosis in esophageal squamous cell carcinoma. APMIS 107, 514-522 (1999) (Pubitemid 29202908)
15. Davidson B., I. Goldberg, W. H. Gtlied, L. Lerner-Geva, G. Ben-Baruch, L. Aqulansky, I. Novikov & J. Kopolovic: Macrophage infiltration and angiogenesis in cervical squamous cell carcinoma - clinicopathologic correlation. Acta Obstet Gynecol Scand 78, 240-244 (1999) (Pubitemid 29110289)
16. Heller D. S., M. Hameed, B. Cracchiolo, M. Wiederkehr, D. Scott, J. Skurnick, N. Ammar & W. C. Lambert: Presence and quantification of macrophages in squamous cell carcinoma of the cervix. Int J Gynecol Cancer 13, 67-70 (2003) (Pubitemid 36292728)
17. Takanami I., K. Takeuchi & S. Kodaira: Tumor-associated macrophage infiltration in pulmonary adenocarcinoma: association with angiogenesis and poor prognosis. Oncology 57, 138-142 (1999) (Pubitemid 29385492)
18. Tataroglu C., A. Kargi, S. Ozkal, N. Esrefoglu & A. Akkoclu: Association of macrophages, mast cells and eosinophil leukoytes with angiogenesis and tumor stage in non-small cell lung carcinomas (NSCLC). Lung Cancer 43, 47-54 (2004) (Pubitemid 38096291)
19. Welsh T. J., R. H. Green, D. Richardson, D. A. Waller, K. J. O'Byrne & P. Bradding: Macrophage and mast-cell invasion of tumour islets confers a marked survival advantage in non-small-cell lung cancer. J Clin Oncol 23, 8959-8967 (2005) (Pubitemid 46211481)
20. Nakayama Y., N. Nagashima, N. Minagawa, Y. Inoue, T. Katsuki, K. Onitsuka, T. Sako, K. Hirata, N. Nagata & H. Itoh: Relationships between tumor-associated macrophages and clinicopathological factors in patients with colorectal cancer. Anticancer Res 22, 4291-4296 (2002) (Pubitemid 36134475)
21. Tan S. Y., Y. Fan, H. S. Luo, Z. X. Shen, Y. Guo & L. J. Zhao: Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer. World J Gastroenterol 11, 1210-1214 (2005) (Pubitemid 40353010)
22. Funada Y., T. Noguchi, R. Kikuchi, S. Takeno, Y. Uchida & H. E. Gabbert: Prognostic significance of CD8+ T cell and macrophage peritumoural infiltration in colorectal cancer. Oncol Rep 19, 309-313 (2003)
23. Lissbrant I. F., P. Stattin, P. Wikstrom, J. E. Damber, L. Egevad & A. Bergh: Tumour associated macrophages in human prostate cancer: relation to clinicopathological variables and survival. Int J Oncol 17, 445-451 (2000)
24. Farinha P., H. Masoudi, B. F. Skinnider, K. Shumansky, J. J. Spinelli, K. Gill, R. Klasa, N. Voss, J. M. Connors & R. D. Gascoyne: Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood 106, 2169-2174 (2005) (Pubitemid 41291735)
25. Glas A. M., L. Knoops, L. Delahaye, M. J. Kersten, R. E. Kibbelaar, L. A. Wessels, R. van Laar, J. H. van Krieken, J. W. Baars, J. Raemaekers, P. M. Kluin, L. J. van't Veer & D. de Jong: Gene expression and immunohistochemical study of specific T cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. J Clin Oncol 25, 390-398 (2007) (Pubitemid 350002987)
26. Marcus B., D. Arenberg, J. Lee, C. Kleer, D. B. Chepeha, C. E. Schmalbach, M. Islam, S. Paul, Q. Pan, S. Hanash, R. Kuick, S. D. Merajver & T. N. Teknos: Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma. Cancer 101, 2779-2787 (2004)
27. Ohno S., H. Inagawa, D. K. Dhar, T. Fujii, S. Ueda, M. Tachibana, N. Suzuki, M. Inoue, G. Soma & N. Nagasue: The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients. Anticancer Res 23, 5015-5022 (2003) (Pubitemid 38182119)
28. Setty B. N. & M. J. Stuart: Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease. Blood 88, 2311-2320 (1996) (Pubitemid 26307936)
29. Dore-Duffy P., R. Balabanov, T. Beaumont, M. A. Hritz, S. I. Harik & J. C. LaManna: Endothelial activation following prolonged hypobaric hypoxia. Microvasc Res 57, 75-85 (1999) (Pubitemid 29393284)
30. Ng C. K., S. S. Deshpande, K. Irani & B. R. Alevriadou: Adhesion of flowing monocytes to hypoxiareoxygenation-exposed endothelial cells: role of Rac1, ROS and VCAM-1. Am J Physiol Cell Physiol 283, C93-102 (2002) (Pubitemid 34670552)
31. Kim I., S. O. Moon, S. K. Park, S. W. Chae & G. Y. Koh: Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1 and E-selectin expression. Circ Res 89, 477-479 (2001) (Pubitemid 34132640)
32. Ley K.: Arrest chemokines. Microcirculation 10, 289-295 (2003) (Pubitemid 39004256)
33. Luboshits G., S. Shina, O. Kaplan, S. Engelberg, D. Nass, B. Lifshitz-Mercer, S. Chaitchik, I. Keydar & A. Ben-Baruch: Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res 59, 4681-4687 (1999) (Pubitemid 29428976)
34. Niwa Y., H. Akamatsu, H. Niwa, H. Sumi, Y. Ozaki & A. Abe: Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin Cancer Res 7, 285-289 (2001) (Pubitemid 32183031)
35. Baier P. K., S. Eggstein, G. Wolff-Vorbeck, U. Baumgartner & U. T. Hopt: Chemokines in human colorectal carcinoma. Anticancer Res 25, 3581-3584 (2005) (Pubitemid 41105244)
36. Cuenca R. E., R. G. Azizkhan & S. Hasgill: Characterisation of GRO alpha, beta and gamma expression in human colonic tumours: potential significance of cytokine involvement. Surg Oncol 1, 323-329 (1992)
37. Mrowietz U., U. Schwenk, S. Maune, J. Bartels, M. Kupper, I. Fichtner, J. M. Schroder & D. Schadendorf: The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice. Br J Cancer 79, 1025-1031 (1999) (Pubitemid 29087870)
38. Tettelbach W., L. Nanney, D. Ellis, L. King & A. Richmond: Localization of MGSA/GRO protein in cutaneous lesions. J Cutan Pathol 20, 259-266 (1993) (Pubitemid 23210546)
39. Ueno T., M. Toi, H. Saji, M. Muta, H. Bando, K. Kuroi, M. Koike, H. Inadera & K. Matsushima: Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin Cancer Res 6, 3282-3289 (2000) (Pubitemid 30637758)
40. Negus R. P., G. W. Stamp, M. G. Relf, F. Burke, S. T. Malik, S. Bernasconi, P. Allavena, S. Sozzani, A. Mantovani & F. R. Balkwill: The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest 95, 2391-2396 (1995)
41. Arenberg D. A., M. P. Keane, B. DiGiovine B, S. L. Kunkel, S. R. Strom, M. D. Burdick, M. D. Iannettoni & R. M. Streiter: Macrophage infiltration in human non-smallcell lung cancer: the role of CC chemokines. Cancer Immunol Immunother 49, 63-70 (2000) (Pubitemid 30431641)
42. Nesbit M., H. Schaider, T. H. Miller & M. Herlyn: Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumour formation in nontumourigenic melanoma cells. J Immunol 166, 6483-6490 (2001) (Pubitemid 32467185)
43. Hoshino Y., K. Hatake, T. Kasahara, Y. Takahashi, M. Ikeda, H. Tomizuka, T. Ohtsuki, M. Uwai, N. Mukaida & K. Matsushima: Monocyte chemoattractant protein-1 stimulates tumour necrosis and recruitment of macrophages into tumours in tumour-bearing nude mice: increased granulocyte and macrophage progenitors in bone marrow. Exp Hematol 23, 1035-1039 (1995)
44. Locati M., U. Deuschle, M. L. Massardi, F. O. Martinez, M. Sironi, S. Sozzani, T. Bartfai & A. Mantovani: Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes. J Immunol 168, 3557-3562 (2002) (Pubitemid 34250425)
45. Schenkel A. R., Z. Mamdouh, X. Chen, R. M. Liebman & W. A. Muller: CD99 plays a major role in the migration of monocytes through endothelial junctions. Nat Immunol 3, 143-150 (2002) (Pubitemid 34141444)
46. Kalra V. K., Y. Shen, C. Sultana & V. Rattan: Hypoxia induces PECAM-1 phosphorylation and transendothelial migration of monocytes. Am J Physiol 271, H2025-2034 (1996)
47. Zhou J. H., F. Ye, H. Z. Chen, C. Y. Zhou, W. G. Lu & X. Xie: Altered expression of cellular membrane molecules of HLA-DR, HLA-G and CD99 in cervical intraepithelial neoplasias and invasive squamous cell carcinoma. Life Sci 78, 2643-2649 (2006)
48. Shen J., H. E. Zhau, S. D. Hursting & L. W. Chung: Androgen regulation of the human pseudoautosomal gene MIC2, a potential marker for prostate cancer. Mol Carcinog 23, 13-19 (1998) (Pubitemid 28441055)
49. Wykoff C. C., C. W. Pugh, P. H. Maxwell, A. L. Harris & Ratcliffe P. J: Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential display profiling. Oncogene 19, 6297-6305 (2000) (Pubitemid 32641843)
50. Helmlinger G., F. Yuan, M. Dellian & R. K. Jain: Interstitial pH and pO2 gradients in solid tumours in vivo: high resolution measurements reveal a lack of correlation. Nat Med 3, 177-182 (1997) (Pubitemid 27064702)
51. Brizel D. M., G. L. Rosner, L. R. Prosnitz & M. W. Dewhirst: Patterns and variability of tumour oxygenation in human soft tissue sarcomas, cervical carcinomas and lymph node metastases. Int J Radiat Oncol Biol Phys 32, 1121-1125 (1995)
52. Murdoch C., A. Giannoudis & C. E. Lewis: Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumours and other ischaemic tissues. Blood 104, 2224-2234 (2004) (Pubitemid 39331817)
53. Balkwill F.: Cancer and the chemokine network. Nat Rev Cancer 4, 540-550 (2004) (Pubitemid 38868623)
54. Barleon B., S. Sozzani, D. Zhou, H. A. Weich, A. Montavani & D. Marme: Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87, 3336-3343 (1996) (Pubitemid 26115364)
55. Leek R. D., N. C. Hunt, R. J. Landers, C. E. Lewis, J. A. Royds & A. L. Harris: Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J Pathol 190, 430-436 (2000) (Pubitemid 30163582)
56. Forsythe J. A., B. H. Jiang, N. V. Iver, F. Agani, S. W. Leung, R. D. Koos & G. L. Semenza: Activation of vascular endothelial growth factor gene transcription by hypoxia inducible factor 1. Mol Cell Biol 16, 4604-4613 (1996) (Pubitemid 26272112)
57. Lee A. H., E. A. Dublin, L. G. Bobrow & R. Poulsom: Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis. J Pathol 185, 394-401 (1998) (Pubitemid 28355972)
58. Lewis J. S., R. J. Landers, J. C. Underwood, A. L. Harris & C. E. Lewis: Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularised areas of breast carcinomas. J Pathol 192, 150-158 (2000)
59. Schioppa T., B. Uranchimeg, A. Saccani, S. K. Biswas, A. Doni, A. Rapisarda, S. Bernasconi, S. Saccani, M. Nebuloni, L. Vago, A. Mantovani, G. Melillo & A. Sica: Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med 198, 1391-1402 (2003) (Pubitemid 37392484)
60. Grant K., M. Loizidou & I. Taylor: Endothelin-1: a multifunctional molecule in cancer. Br J Cancer 88, 163-166 (2003)
61. Grimshaw M. J., J. L. Wilson & F. R. Balkwill: Endothelin-2 is a macrophage chemoattractant: implications for macrophage distribution in tumors. Eur J Immunol 32, 2393-2400 (2002)
62. Cui P., K. Tani, H. Kitamura, Y. Okumura, M. Yano, D. Inui, T. Tamaki, S. Sone & H. Kido: A novel bioactive 31-amino acid endothelin-1 is a potent chemotactic peptide for human neutrophils and monocytes. J Leukoc Biol 70, 306-312 (2001) (Pubitemid 32751523)
63. Grimshaw M. J., S. Naylor & F. R. Balkwill: Endothelin-2 is a hypoxia-induced autocrine survival factor for breast tumour cells. Mol Cancer Ther 9, 1273-1281 (2002)
64. Matschurat S., U. E. Knies, V. Person, L. Fink, B. Stoelcker, C. Ebenebe, H. A. Behrensdorf, J. Schaper & M. Clauss: Regulation of EMAP II by hypoxia. Am J Pathol 162, 93-103 (2003) (Pubitemid 36041992)
65. Daemen M. A., C. van't Veer, G. Denecker, V. H. Heemskerk, T. G. Wolfs, M. Clauss, P. Vandenabeele & W. A. Buurman: Inhibition of apoptosis induced by ischaemia-reperfusion prevents inflammation. J Clin Invest 104, 541-549 (1999)
66. Clarijs R., L. Schalkwijk, D. J. Ruiter & R. M. de Waal: EMAP II expression is associated with macrophage accumulation in primary uveal melanoma. Invest Ophthalmol Vis Sci 44, 1801-1806 (2003) (Pubitemid 36520264)
67. Bosco M. C., G. Reffo, M. Puppo & L. Varesio: Hypoxia inhibits the expression of the CCR5 chemokine receptor in macrophages. Cell Immunol 228, 1-7 (2004) (Pubitemid 38760116)
68. Negus R. P., L. Turner, F. Burke & F. R. Balkwill: Hypoxia down-regulates MCP-1 expression: implications for macrophage distribution in tumours. J Leukoc Biol 63, 758-765 (1998) (Pubitemid 28274839)
69. Bosco M. C., M. Puppo, S. Pastorino, Z. Mi, G. Melillo, S. Massazza, A. Rapisarda & L. Varesio: Hypoxia selectively inhibits monocyte chemoattractant protein-1 production by macrophages. J Immunol 172, 1681-1690 (2004) (Pubitemid 38116816)
70. Negus R. P., G. W. Stamp, J. Hadley & F. R. Balkwill: Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am J Pathol 150, 1723-1734 (1997) (Pubitemid 27193819)
71. Bacher M., J. Schrader, N. Thompson, K. Kuschela, D. Gemsa, G. Waeber & J. Schlegel: Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumour cells during hypoxic and hypoglycaemic stress indicates a critical role for abgiogenesis in glioblastoma multiforme. Am J Pathol 162, 11-17 (2003) (Pubitemid 36041985)
72. Bando H., M. Toi, K. Kitada & M. Koike: Genes commonly upregulated by hypoxia in human breast cancer cells MCF-7 and MDA-MB-231. Biomed Pharmacother 57, 333-340 (2003) (Pubitemid 37237600)
73. White J. R., R. A. Harris, S. R. Lee, M. H. Craigon, K. Binley, T. Price, G. L. Beard, C. R. Mundy & S. Naylor: Genetic amplification of the transcriptional response to hypoxia as a novel means of identifying regulators of angiogenesis. Genomics 83, 1-8 (2004) (Pubitemid 37518254)
74. David J. R.: Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cellantigen interaction. Proc Natl Acad Sci USA 56, 72-77 (1966)
75. Bloom B. R. & B. Bennett: Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153, 80-82 (1966)
76. Mitchell R. A.: Mechanisms and effectors of MIF-dependent promotion of tumourigenesis. Cell Signal 16, 13-19 (2004) (Pubitemid 37357187)
77. Bosco M. C., M. Puppo, C. Santangelo, L. Anfosso, U. Pfeffer, P. Fardin, F. Battaglia & L. Varesio: Hypoxia modifies the transcriptome of primary human monocytes: modulation of novel immune-related genes and identification of CC-chemokine ligand 20 as a new hypoxia-inducible gene. J Immunol 177, 1941-1955 (2006) (Pubitemid 44092535)
78. Smith D. F., E. Galkina, K. Ley & Y. Huo: GRO family cytokines are specialised for monocyte arrest from flow. Am J Physiol Heart Circ Physiol 289, H1976-1984 (2005) (Pubitemid 41507347)
79. Mestas J., M. D. Burdick, K. Reckamp, R. A. Figlin & R. M. Strieter: The role of CXCR2/CXCR2 ligand biological axis in renal cell carcinoma. J Immunol 175, 5351-5357 (2005) (Pubitemid 41456421)
80. Grimshaw M. J. & F. R. Balkwill: Inhibition of macrophage chemotaxis by hypoxia and inflammation - a potential mechanism. Eur J Immunol 31, 480-489 (2001) (Pubitemid 32166603)
81. Rouseau S., F. Houle, J. Landry & J. Huot: p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganisation and cell migration in human endothelial cells. Oncogene 15, 2169-2177 (1997) (Pubitemid 27493906)
82. Leek R. D., C. E. Lewis & A. L. Harris: The role of macrophages in tumour angiogenesis. In: Tumour Angiogenesis. Eds: Bicknell R., Lewis C. E. Oxford University Press, Oxford, UK (1997)
83. Carmeliet P.: VEGF as a key mediator of angiogenesis in cancer. Oncology 69, 4-10 (2005) (Pubitemid 41680947)
84. Harris A. L.: Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2, 38-47 (2002) (Pubitemid 37328806)
85. Epstein A. C. R., J. M. Gleadle, L. A. McNeill, K. S. Hewitson, J. O'Rourke, D. R. Mole, M. Mukherji, E. Metzen, M. I. Wilson, A. Dhanda, Y. M. Tian, N. Masson, D. L. Hamilton, P. Jaakkola, R. Barstead, J. Hodgkin, P. H. Maxwell, C. W. Pugh, C. J. Schofield & P. J. Ratcliffe: C. elegans EGL-9 and mammalian homologues define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 42-54 (2001)
86. Bruick R. K. & S. L. McKnight. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294, 1337-40 (2001) (Pubitemid 33063099)
87. Maxwell P. H., G. U. Dachs, J. M. Gleadle, L. G. Nicholls, A. L. Harris, I. J. Stratford, O. Hankinson, C. W. Pugh & P. J. Ratcliffe: Hypoxia-inducible factor-1 modulates gene expression in solid tumours and influences both angiogenesis and tumour growth. Proc Natl Acad Sci USA 94, 8104-(1997)
88. Ryan H. E., J. Lo, R. S. Johnson: HIF-1 alpha is required for solid tumour formation and embryonic vascularisation. EMBO 17, 3005-3015 (1998) (Pubitemid 28254373)
89. Griffiths L., K. Binley, S. Iqball, O. Kan, P. Maxwell, P. Ratcliffe, C. Lewis, A. Harris, S. Kingman & S. Naylor. The macrophage - a novel system to deliver gene therapy to pathological hypoxia. Gene Ther 7, 255-262 (2000) (Pubitemid 30113775)
90. Burke B., T. N. Tang, K. P. Corke, D. Tazzyman, K. Ameri, M. Wells & C. E. Lewis: Expression of HIF-1 alpha by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer therapy. J Pathol 196, 204-12 (2002) (Pubitemid 34110902)
91. Talks K. L., H. Turley, K. C. Gatter, P. H. Maxwell, C. W. Pugh, P. J. Ratcliffe & A. L. Harris: The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 157, 411-421 (2000) (Pubitemid 30626905)
92. Leek R. D., K. L. Talks, F. Pezzella, H. Turley, L. Campo, N. S. Brown, R. Bicknell, M. Taylor, K. C. Gatter & A. L. Harris: Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in human breast cancer. Cancer Res 62, 1326-1329 (2002) (Pubitemid 34407787)
93. Onita T., P. G. Ji, J. W. Xuan, H. Sakai, H. Kanetake, P. H. Maxwell, G. H. Fong, M. Y. Gabril, M. Moussa & J. L. Chin: Hypoxia-induced, perinecrotic expression of endothelial Per-ARNT-Sim domain protein-1/hypoxiainducible factor-2alpha correlates with tumor progression, vascularization, and focal macrophage infiltration in bladder cancer. Clin Cancer Res 8, 471-480 (2002) (Pubitemid 34193967)
94. Shatrov V. A., V. V. Sumbayev, J. Zhou & B. Brune: Oxidised low-density lipoprotein (oxLDL) triggers hypoxia-inducible factor-1a (HIF-1a) accumulation via redox-dependent mechanisms. Blood 101, 4847-4849 (2003) (Pubitemid 36857745)
95. Blouin C. C., E. L. Page, G. M. Soucy & D. E. Richard: Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1a. Blood 103, 1124-1130 (2004) (Pubitemid 38129580)
96. Li J., M. Post, R. Volk, Y. Gao, M. Li, C. Metais, K. Sato, J. Tsai, W. Aird, R. D. Rosenberg, T. G. Hampton, F. Sellke, P. Carmeliet & M. Simons: PR39, a peptide regulator of angiogenesis. Nat Med 6, 49-55 (2000) (Pubitemid 30048525)
97. Knowles H. J., D. R. Mole, P. J. Ratcliffe & A. L. Harris: Normoxic stabilisation of Hypoxia-Inducible Factor-1 alpha by modulation of the labile iron pool in differentiating U937 macrophages: effect of Natural Resistance-Associated Macrophage Protein 1. Cancer Res 66, 2600-2607 (2006)
98. Cramer T., Y. Yamanishi, B. E. Clausen, I. Forster, R. Pawlinski, N. Mackman, V. H. Haase, R. Jaenisch, M. Corr, V. Nizet, G. S. Firestein, H. P. Gerber, N. Ferrara & R. S. Johnson: HIF-1alpha is essential for myeloid cell mediated inflammation. Cell 112, 645-657 (2003) (Pubitemid 36331777)
99. Weidner N., J. Folkman, F. Pozza, P. Bevilacqua, E. N. Allred, D. H. Moore, S. Meli & G. Gasparini: Tumour angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84, 1875-1887 (1992) (Pubitemid 23004615)
100. Nishie A., M. Ono, T. Shono, J. Fukushi, M. Otsubo, H. Onoue, Y. Ito, T. Inamura, K. Ikezaki, M. Fukui, T. Iwaki & M. Kuwano: Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res 5, 1107-1113 (1999) (Pubitemid 29233226)
101. Orre M. & P. A. Rogers: Macrophages and microvessel density in tumours of the ovary. Gynecol Oncol 73, 47-50 (1999) (Pubitemid 29177598)
102. Li C., S. Shintani, N. Terakado, K. Nakashiro & H. Hamakawa: Infiltration of tumour-associated macrophages in human oral squamous carcinoma. Oncol Rep 9, 1219-1223 (2002)
103. Leek R. D., R. J. Landers, A. L. Harris & C. E. Lewis: Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 79, 991-995 (1999) (Pubitemid 29082138)
104. Esposito I., M. Menicagli, N. Funel, F. Bergmann, U. Boggi, F. Mosca, G. Bevilacqua & D. Campani: Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J Clin Pathol 57, 630-636 (2004) (Pubitemid 38725766)
105. Bingle L., C. E. Lewis, K. P. Corke, M. W. Reed & N. J. Brown: Macrophages promote angiogenesis in human breast tumour spheroids in vivo. Br J Cancer 94, 101-107 (2006) (Pubitemid 43088548)
106. Gunaratnam L., M. Morley, A. Franovic, N. de Paulsen, K. Mekhail, D. A. Parolin, E. Nakamura, I. A. Lorimer & S. Lee: Hypoxia-inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL (-/-) renal cell carcinoma cells. J Biol Chem 278, 44966-44974 (2003) (Pubitemid 37377256)
107. Petrella B. L., J. Lohi & C. E. Brinkerhoff: Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel Lindau renal cell carcinoma. Oncogene 24, 1043-1052 (2005) (Pubitemid 40313881)
108. Burke B., A. Giannoudis, K. P. Corke, D. Gill, M. Wells, L. Ziegler-Heitbrock & C. E. Lewis: Hypoxiainduced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. Am J Pathol 163, 1233-1243 (2003) (Pubitemid 37175073)
109. Huang S., M. Van Arsdall, S. Tedjarati, M. McCarty, W. Wu, R. Langley & I. J. Fidler: Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst 94, 1134-1142 (2002) (Pubitemid 34919050)
110. Giraudo E., M. Inoue & D. Hanahan: An aminobisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest 114, 623-633 (2004) (Pubitemid 39578752)
111. Miles D. W., L. C. Happerfield, M. S. Naylor, L. G. Bobrow, R. D. Rubens & F. R. Balkwill: Expression of tumour necrosis factor (TNF alpha) and its receptors in benign and malignant breast tissue. Int J Cancer 56, 777-782 (1994) (Pubitemid 24102739)
112. Nagaoka H., Y. Iino, H. Takei & Y. Morishita: Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in macrophages correlates with tumour angiogenesis and prognosis in invasive breast cancer. Int J Oncol 13, 449-454 (1998) (Pubitemid 28372665)
113. Kitazono M., Y. Takebayashi, K. Ishitsuka, S. Takao, A. Tani, T. Furukawa, K. Miyadera, Y. Yameda, T. Aikou & S. Akiyama: Prevention of hypoxia-induced apoptosis by the angiogenic factor thymidine phosphorylase. Biochem Biophys Res Commun 253, 797-803 (1998) (Pubitemid 29039222)
114. Leek R. D., R. Landers, S. B. Fox, F. Ng, A. L. Harris & C. E. Lewis: Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. Br J Cancer 77, 2246-2251 (1998) (Pubitemid 28263948)
115. Yao Y., T. Kubota, K. Sato & R. Kitai: Macrophage infiltration-associated thymidine phosphorylase expression correlates with increased microvessel density and poor prognosis in astrocytic tumours. Clin Cancer Res 7, 4021-4026 (2001) (Pubitemid 34044622)
116. Hagemann T., S. C. Robinson, M. Schulz, L. Trumper, F. R. Balkwill & C. Binder: Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteinases. Carcinogenesis 25, 1542-1549 (2004)
117. Wang J. M., J. D. Griffin, A. Rambaldi, Z. G. Chen & A. Mantovani: Induction of monocyte migration by recombinant macrophage colony-stimulating factor. J Immunol 141, 575-579 (1988)
118. Aharinejad S., P. Paulus, M. Sioud, M. Hofmann, K. Zins, R. Schafer, E. R. Stanley & D. Abraham: Colonystimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumour xenografts in mice. Cancer Res 64, 5378-5384 (2004) (Pubitemid 39006559)
119. Lin E. Y., A. V. Nguyen, R. G. Russell & J. W. Pollard: Colony stimulating factor 1 promotes progression of mammary tumours to malignancy. J Exp Med 193, 727-740 (2001)
120. Condeelis J. & J. W. Pollard: Macrophages: obligate partners for tumor cell migration, invasion and metastasis. Cell 124, 263-266 (2006) (Pubitemid 43121975)
121. Chen A. C., E. Y. Chen & A. J. Giaccia: Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. Cancer Res 54, 1425-1430 (1994) (Pubitemid 24106401)
122. Yan S. F., J. Lu, Y. S. Zou, J. Soh-Won, D. M. Cohen, P. M. Buttrick, D. R. Cooper, S. F. Steinberg, N. Mackman, D. J. Pinsky & D. M. Stern: Hypoxia-associated induction of early growth response-1 gene expression. J Biol Chem 274, 15030-15040 (1999)
123. Peters C. L., C. J. Morris, P. I. Mappm, D. R. Blake, C. E. Lewis & V. R. Winrow: The transcription factors hypoxia-inducible factor 1alpha and Ets-1 colocalize in the hypoxic synovium of inflamed joints in adjuvant-induced arthritis. Arthritis Rheum 50, 291-296 (2004) (Pubitemid 38084314)
124. Brown N. S., A. Jones, C. Fujiyama, A. L. Harris & R. Bicknell: Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors. Cancer Res 60, 6298-6302 (2000)
125. Beasley N. J. P., R. Prevo, S. Banerji, R. D. Leek, J. Moore, P. van Trappen, G. Cox, A. L. Harris & D. G. Jackson: Intratumoral lymphangiogenesis and lymph node metastasis in head and neck cancer. Cancer Res 62, 1315-1320 (2002) (Pubitemid 34407785)
126. Hall F. T., J. L. Freeman, S. L. Asa, D. G. Jackson & N. J. Beasley: Intratumoral lymphatics and lymph node metastases in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 129, 716-719 (2003) (Pubitemid 36858956)
127. Straume O., D. G. Jackson & L. A. Akslen: Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. Clin Cancer Res 9, 250-256 (2003) (Pubitemid 36109741)
128. Schoppman S. F., A. Fenzl, K. Nagy, S. Unger, G. Bayer, S. Geleff, M. Gnant, R. Horvat, R. Jakesz & P. Birner: VEGF-C expressing tumour-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Surgery 139, 839-846 (2006) (Pubitemid 43902914)
129. Schoppman S. F., P. Birner, J. Stockl, R. Kalt, R. Ullrich, C. Caucig, E. Kriehuber, K. Nagy, K. Alitalo & D. Kerjaschki: Tumour-associated macrophages express lymphatic endothelial growth factors and are related to peritumoural lymphangiogenesis. Am J Pathol 161, 947-957 (2002)
130. Cursiefen C., L. Chen, L. P. Borges, D. Jackson, J. Cao, C. Radziejewski, P. A. D'Amore, M. R. Dana, S. J. Wiegand & J. W. Streilein: VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularisation via macrophage recruitment. J Clin Invest 113, 1040-1050 (2004) (Pubitemid 38544126)
131. Maruyama K., M. Ii, C. Cursiefen, D. G. Jackson, H. Keino, M. Tomita, N. Van Rooijen, H. Takenaka, P. A. D'Amore, J. Stein-Streilen, D. W. Losordo & J. W. Streilein: Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 115, 2316-2319 (2005)
132. Wyckoff J., W. Wang, E. Y. Lin, Y. Wang, F. Pixley, E. R. Stanley, T. Graf, J. W. Pollard, J. Segall & J. Condeelis: A paracrine loop between tumour cells and macrophages is required for tumour cell migration in mammary tumours. Cancer Res 64, 7022-7029 (2004) (Pubitemid 39331012)
133. Goswami S., E. Sahai, J. B. Wyckoff, M. Cammer, D. Cox, F. J. Pixley, E. R. Stanley, J. E. Segall & J. S. Condeelis: Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 65, 5278-5283 (2005) (Pubitemid 40827339)
134. Kryczek I., L. Zou, P. Rodriguez, G. Zhu, S. Wei, P. Mottram, M. Brumlik, P. Cheng, T. Curiel, L. Myers, A. Lackner, X. Alvarez, A. Ochoa, L. Chen & W. Zou: B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. J Exp Med 203, 871-881 (2006)
135. Elgert K. D., D. G. Alleva & D. W. Mullins: Tumourinduced immune dysfunction: the macrophage connection. J Leukoc Biol 64, 275-290 (1998) (Pubitemid 28409233)
136. Ben-Baruch A.: Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. Semin Cancer Biol 16, 38-52 (2006) (Pubitemid 43139708)
137. Gordon I. O. & R. S. Freedman: Defective antitumour function of monocyte-derived macrophages from epithelial ovarian cancer patients. Clin Cancer Res 12, 1515-1524 (2006)
138. Grant V., A. E. King, E. Faccenda & R. W. Kelly: PGE/cAMP and GM-CSF synergise to induce a protolerance cytokine profile in monocytic cell lines. Biochem Biophys Res Commun 331, 187-193 (2005) (Pubitemid 40545160)
139. Satoh T., T. Saika, S. Ebara, N. Kusaka, T. L. Timme, G. Yang, J. Wang, V. Mouraviev, G. Cao, M. A. el Fattah & T. C. Thompson: Macrophages transduced with an adenoviral vector expressing interleukin 12 suppress tumour growth and metastasis in a preclinical metastatic prostate cancer model. Cancer Res 63, 853-7860 (2003)
140. Sun Z., Z. Yao, S. Liu, H. Tang & X. Yan: An oligonucleotide decoy for Stat3 activates the immune response of macrophages to breast cancer. Immunobiology 211, 199-209 (2006) (Pubitemid 43337760)
141. Fingleton B., T. Vargo-Gogola, H. C. Crawford & L. M. Matrisian: Matrilysin (MMP-7) expression selects for cells with reduced sensitivity to apoptosis. Neoplasia 3, 459-468 (2001) (Pubitemid 33151012)
142. Ohno S., H. Inagawa, D. K. Dhar, T. Fujii, S. Ueda, M. Tachibana, N. Suzuki, M. Inoue, G. Soma & N. Nagasue: The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients. Anticancer Res 23, 5015-5022 (2003) (Pubitemid 38182119)
143. Boonman Z. F., L. R. Schurmans, N. van Rooijen, C. J. Melief, R. E. Toes & M. J. Jager: Macrophages are vital in spontaneous intraocular tumour eradication. Invest Ophthalmol Vis Sci 47, 2959-2965 (2006) (Pubitemid 351639772)
144. Biswas S. K., L. Gangi, P. Saki, T. Schioppa, A. Saccani, M. Sironi, B. Bottazzi, A. Doni, B. Vincenzo, F. Pasqualini, L. Vago, M. Nebuloni, A. Mantovani & A. Sica: A distinct and unique transcriptional programme expressed by tumour-associated macrophages (defective NF-?B and enhanced IRF-3/STAT1 activation). Blood 107, 2112-2122 (2006) (Pubitemid 43289397)
145. Ben-Baruch A.: The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev 25, 357-371 (2006) (Pubitemid 44922355)
146. Belperio J. A., M. P. Keane, D. A. Arenberg, C. L. Addison, J. E. Ehlert, M. D. Burdick & R. M. Strieter: CXC chemokines in angiogenesis. J Leukoc Biol 68, 1-8 (2000)
147. Luster A. D. & P. Leder: IP-10, a C-X-C chemokine, elicits a potent thymus-dependent antitumour response in vivo. J Exp Med 178, 1057-1065 (1993) (Pubitemid 23260444)
148. Palmer K., M. Hitt, P. C. Emtage, S. Gyorffy & J. Gauldie: Combined CXC chemokine and interleukin-12 gene transfer enhances antitumour immunity. Gene Ther 8, 282-290 (2001) (Pubitemid 32237061)
149. Nakanishi T., K. Imaizumi, Y. Hasegawa, T. Kawabe, N. Hashimoto, M. Okamoyo & K. Shimokata: Expression of macrophage-derived (MDC)/CCL22 in human lung cancer. Cancer Immunol Immunother 55, 1320-1329 (2006) (Pubitemid 44187663)
150. Wagsater D., A. Hugander & J. Dimberg: Expression of CXCL16 in human rectal cancer. Int J Mol Med 14, 65-69 (2004)
151. Houghton A. M., J. L. Grisolano, M. L. Baumann, D. K. Kobayashi, R. D. Hautamaki, L. C. Nehring, L. A. Cornelius & S. D. Shapiro: Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases. Cancer Res 66, 6149-6155 (2006)
152. Kerkela E., R. Ala-aho, P. Klemi, S. Grenman, S. D. Shapiro, V. M. Kahari & U. Saarialho-Kere: Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome. J Pathol 198, 258-269 (2002) (Pubitemid 35243885)
153. Kaduka Y., K. Takeda, M. Nakayama, K. Kinoshita, H. Yagita & K. Okumara: TWEAK mediates anti-tumour effect of tumour-infiltrating macrophages. Biochem Biophys Res Commun 331, 384-390 (2005) (Pubitemid 40602649)
154. Baron-Bodo V., P. Doceur, M. L. Lefebvre, K. Labroquere, C. Defaye, C. Cambouris, D. Prigent, M. Salcedo, A. Boyer & A. Nardin: Anti-tumour properties of human-activated macrophages produced in large scale for clinical application. Immunobiology 210, 267-277 (2005) (Pubitemid 41025168)
155. Lei H., D. W. Ju, Y. Yu, Q. Tao, G. Chen, S. Gu, H. Hamada & X. Cao: Induction of potent antitumour response by vaccination with tumour lysate-pulsed macrophages engineered to secrete macrophage colonystimulating factor and interferon-gamma. Gene Ther 7, 707-713 (2000) (Pubitemid 30255776)
156. Hennemann B., G. Beckmann, A. Eichelmann, A. Rehm & R. Andreesen: Phase I trial of adoptive immunotherapy of cancer patients using monocyte-derived macrophages activated with interferon gamma and lipopolysaccharide. Cancer Immunol Immunother 45, 250-256 (1998) (Pubitemid 128759559)
157. Andreesen R., B. Hennemann & S. W. Krause: Adoptive immunotherapy of cancer using monocytederived macrophages: rationale, current status and perspectives. J Leukoc Biol 64, 419-426 (1998) (Pubitemid 28455386)
158. Ritchie D., L. Mileshkin, D. Wall, J. Bartholeyns, M. Thompson, J. Coverdale, E. Lau, J. Wong, P. Eu, R. J. Hicks & H. M. Prince: In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma. Cancer Immunol Immunother 56, 155-163 (2006) (Pubitemid 44833090)
159. Carta L., S. Pastorino, G. Melillo, M. C. Bosco, S. Massazza & L. Varesio: Engineering of macrophages to produce IFN-gamma in response to hypoxia. J Immunol 166, 5374-5380 (2001) (Pubitemid 32374156)
160. Reddy R. K., L. Dubeau, H. Kleiner, T. Parr, P. Nichols, B. Ko, D. Dong, H. Ko, C. Mao, J. DiGiovanni & A. S. Lee: Cancer-inducible transgene expression by the Grp94 promoter: spontaneous activation in tumours of various origins and cancer-associated macrophages. Cancer Res 62, 7207-7212 (2002) (Pubitemid 36025240)
161. Guiducci C., A. P. Vicari, S. Sangaletti, G. Trinchieri & M. P. Colombo: Redirecting in vivo elicited tumour infiltrating macrophages and dendritic cells towards tumour rejection. Cancer Res 65, 3437-3446 (2005) (Pubitemid 40524630)
162. Kashani-Sabet M., Y. Liu, S. Fong, P. Y. Desprez, S. Liu, G. Tu, M. Nosrati, C. Handumrongkul, D. Liggitt, A. D. Thor & R. J. Debs: Identification of gene function and functional pathways by systemic plasmid-based ribozyme targeting in adult mice. Proc Natl Acad Sci USA 99, 3878-3883 (2002) (Pubitemid 34252199)
163. Van Ginderachter J. A., S. Meerschaut, Y. Liu, L. Brys, K. De Groeve, G. Hassanzadeh-Ghassabeh, G. Raes & P. de Baetselier: Peroxisome proliferators-activated receptor gamma (PPARgamma) ligands reverse CTL suppression by alternatively activated (M2) macrophages in cancer. Blood 108, 525-535 (2006) (Pubitemid 44061352)
164. de Ridder M., V. N. Verovski, M. I. Darvillle, D. L. van den Berge, C. Monsaert, D. L. Eizirik & G. A. Storme: Macrophages enhance the radiosensitising activity of lipid A: a novel role for immune cells in tumour cell radioresponse. Int J Radiol Oncol Biol Phys 60, 598-606 (2004) (Pubitemid 39233482)
165. Lum H. D., I. N. Buhtoiarov, B. E. Schmidt, G. Berke, D. M. Paulnock, P. M. Sondel & A. L. Rakhmilevich: In vivo CD40 ligation can induce T cell-independent antitumour effects that involve macrophages. J Leukoc Biol 79, 1181-1192 (2006) (Pubitemid 44835552)
166. Masztalerz A., N. van Rooijen, W. den Otter & L. A. Everse: Mechanisms of macrophage cytotoxicity in IL-2 and IL-12 mediated tumour regression. Cancer Immunol Immunother 52, 235-242 (2003) (Pubitemid 36535283)
167. Mullins D. W., C. J. Burger & K. D. Elgert: Paclitaxel enhances macrophage IL-12 production in tumour-bearing hosts through nitric oxide. J Immunol 162, 6811-6818 (1999) (Pubitemid 29309409)
168. Majumder B., R. Biswas & U. Chattopadhyay: Prolactin regulates anttumour immune response through induction of tumouricidal macrophages and release of IL-12. Int J Cancer 97, 493-500 (2002) (Pubitemid 34027809)
169. De Santo C., P. Serafini, I. Marigo, L. Dolcetti, M. Bolla, P. Del Soldata, C. Melani, C. Guiducci, M. P. Colombo, M. Iezzi, P. Musiani, P. Zanovello & V. Bronte: Nitroaspirin corrects immune dysfunction in tumourbearing hosts and promotes tumour eradication by cancer vaccination. Proc Natl Acad Sci USA 102, 4185-4190 (2005) (Pubitemid 40388577)
170. Hansen B. D., H. Schmidt, H. von der Maase, P. Sioegren, R. Agger & M. Hokland: Tumour-associated macrophages are related to progression in patients with metastatic melanoma following interleukin-2 based immunotherapy. Acta Oncol 45, 400-405 (2006) (Pubitemid 43884607)